Leander van Eekelen, Enrico Munari, Ilaria Girolami, Albino Eccher, Jeroen van der Laak, Katrien Grünberg, Monika Looijen-Salamon, Shoko Vos, Francesco Ciompi
Artificial intelligence (AI) based quantification of cell-level PD-L1 status enables spatial analysis and allows reliable and reproducible assessment of the tumor proportion score. In this study, we assess the cell-level inter-pathologist agreement as human benchmark for AI development and validation. Three pathologists manually annotated the centers of all nuclei within 53 regions of interest in 12 whole- slide images (40X magnification) of NSCLC cases and classified them as PD-L1 negative/positive tumor cells, PD-L1 positive immune cells or other cells. Agreement was quantified using F1 score analysis, with agreement defined as annotations less than 10 um apart and of the same class. An average of 9044 nuclei (1550 negative, 2367 positive tumor cells, 1244 positive immune cells, 3881 other cells) were manually annotated by the three pathologists. The mean F1 score over pairs of pathologists at dataset level was 0.59 (range 0.54-0.65). When split across classes, the mean per-pair F1 scores stay approximately the same, indicating the readers perform similarly regardless of cell type. Besides human variability in manual point annotations with respect to the center of nuclei, lack of context contributed to disagreement: readers who reported they solely examined the ROIs tended to disagree more with readers that reported they also looked outside the ROIs for additional (morphological/density) information.
In conclusion, agreement on determining the PD-L1 status of individual cells is only moderate, suggesting a role for AI. By quantifying the inter-rater agreement of pathologists, we have created a human benchmark which may serve as an upper bound (and could be combined via majority vote) for the validation of AI at celllevel, something not done previously. Cell-level AI-based assessment of PD-L1 may supersede slide level scoring, adding significant information on the heterogeneity and spatial distribution over the tumor.